Blastomycosis, orchestrated by the formidable Blastomyces dermatitidis, is a systemic fungal infection that leaves its mark on both canines and felines. This elusive condition has a pronounced presence in select North American regions, predominantly within the Mississippi, Ohio, Missouri, Tennessee, and St. Lawrence River valleys. It also extends its reach to three Canadian provinces (Quebec, Ontario, Manitoba), as well as scattered instances across Africa, India, Europe, and Central America. Its fungal stronghold resides within damp, sandy, acidic terrains teeming with organic matter, often concentrated around water bodies.
Unraveling the Disease's Mechanism
The battle begins as cats unwittingly inhale fungal spores into their lungs. After an incubation period of 5 to 12 weeks, clinical signs might emerge, although some infected animals remain asymptomatic without posing contagion risks to others. Blastomycosis has a predilection for the respiratory tract, where pulmonary afflictions mark the most prevalent manifestation (88-94% of canine cases). Once lung involvement takes hold, the yeast form of the organism embarks on a journey throughout the body. The eyes, bones, skin, lymph nodes, subcutaneous tissues, brain, and testes become common targets, with rarer occurrences in the nose, prostate, liver, mammary glands, and heart.
Interestingly, dogs appear more prone to infection compared to other species. While cats and humans can fall victim, their susceptibility is significantly lower. Dogs stand ten times more predisposed than humans and a staggering 100 times more than cats. A significant number of infected animals reside within a quarter-mile radius of water bodies, with surges in cases often following periods of intense rainfall, putting cats who often venture outdoors at a heightened risk.
Untangling the Symptoms
Symptoms hinge on the afflicted organs. Neurological manifestations, ocular issues, and lameness might arise, depending on the disease's course. In specific geographic regions, dog owners should be vigilant for signs like coughing, labored breathing, eye inflammation, enlarged testicles, fever, swollen lymph nodes, skin lesions, bloody urine, urinary discomfort, nasal signs (including bloody discharge), and reduced appetite. Weight loss is common due to decreased food intake. Nasal infections can lead to skull damage and subsequent brain infection.
Decoding Diagnosis and Treatment
Diagnosis involves a multifaceted approach, including physical exams, blood tests, imaging, urinalysis, cultures, serology, and organ biopsies. Fungal serology isn't always definitive and might yield false negatives. The enzyme immunoassay for B. dermatitidis galactomannan antigen, detectable in urine and serum, shows promise with high sensitivity. While treatment spans antifungal medications like itraconazole, ketoconazole, fluconazole, amphotericin B, and combination therapies, the duration varies case by case. Typically administered at home, severe cases may necessitate hospitalization. Respiratory involvement requires activity restriction. In severe instances, intravenous fluids, oxygen, antibiotics for secondary infections, and pain relief are administered. Ocular cases may necessitate systemic and topical corticosteroids, anti-glaucoma agents, or even eye removal in severe cases.
Decoding Prognosis and Prevention
While many pets fare well, the prognosis depends on treatment duration. Itraconazole, fluconazole, or amphotericin-ketoconazole combinations yield recoveries in 50-75% of affected dogs. For dogs with severe lung issues, the prognosis is guarded, but survival beyond the initial 7-10 days of therapy improves outcomes. Nonetheless, mortality rates can peak at 41% in dogs with Blastomyces dermatitidis infections. Vision retention varies among animals with eye involvement, and dogs with brain engagement usually face a grim prognosis. A poor outlook also accompanies cases involving at least three body systems.
Relapses, occurring mostly within the first six months post-treatment, tend to plague dogs with severe onset cases or inadequate treatment periods. Immunity to re-infection isn't guaranteed. After discontinuing therapy, rechecks at 1, 3, and 6 months can flag relapse. Prevention hinges on keeping pets away from afflicted regions.
Translating Zoonotic Implications
Blastomycosis doesn't usually transfer between pets and humans. The fungus targets humans via inhalation or direct contact with spores. Excavation workers and those in wooded, water-laden areas face higher infection risks. Although cross-species or inter-species transmission isn't common, immunocompromised individuals should minimize contact with infected pets, employing gloves for lesion care.
Don't have a vet in your area yet? We can help you find a local veterinarian.
If you have more questions, the GeniusVets Telehealth platform will give you unlimited access to text and/or video calls with board-certified veterinarians! To learn more click here.